A prospective study of community-associated Clostridium difficile infection in Kuwait: Epidemiology and ribotypes

Anaerobe

Volumn 35, Issue PB, 2015, Pages 28-32

  Jamal, Wafaa ^a,b   Pauline, Eunice ^a   Rotimi, Vincent ^a,b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MUBARAK AL KABEER HOSPITAL   (Kuwait)

Author keywords

Clostridium difficile infection; Community acquired; Epidemiology; Kuwait; Ribotypes

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAMPYLOBACTER; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; DIARRHEA; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISEASE TRANSMISSION; FECES ANALYSIS; FEMALE; HUMAN; INCIDENCE; KUWAIT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RIBOTYPING; RISK FACTOR; SALMONELLA; TRAVEL; ADOLESCENT; AGE; CLASSIFICATION; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

CAMPYLOBACTER; CLOSTRIDIUM DIFFICILE; SALMONELLA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; DIARRHEA; FEMALE; HUMANS; INCIDENCE; KUWAIT; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PROSPECTIVE STUDIES; RIBOTYPING; RISK FACTORS; YOUNG ADULT;

EID: 84936818368     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2015.06.006     Document Type: Article

References (46)

1. Bartlett J.G. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin. Infect. Dis. 2008, 46(Suppl. 1):S4-S11.
2. Kelly C.P., LaMont L.T. Clostridium difficile - more difficult than ever. N. Engl. J. Med. 2008, 359:1932-1940.
3. Khanna S., Pardi D.S., Aronson S.L., Kammer P.P., Orenstein R., St Sauver J.L., et al. The epidemiology of community-acquired Clostridium difficile infection: a population based study. Am. J. Gastroenterol. 2012, 107:89-95.
4. Wilcox M.H., Mooney L., Bendall R., Settle C.D., Fawley W.N. A case-control study of community-associated Clostridium difficile infection. J. Antimicrob. Chemother. 2008, 62:388-396.
5. Taori S.K., Wroe A., Hardie H., Gibb A.P., Poxton I.R. A prospective study of community-associated Clostridium difficile infections: the role of antibiotics and co-infections. J. Infect. 2014, 69:134-144.
6. MacCannell D.R., Louie T.J., Gregson D.B., Laverdiere M., Labbe A.C., Laing F., et al. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada. J. Clin. Microbiol. 2006, 44:2147-2152.
7. Naggie S., Frederick J., Pien B.C., Miller B.A., Provenzale D.T., Goldberg K.C., et al. Community-associated Clostridium difficile infection: experience of a veteran medical center in southeastern USA. Infection 2010, 38:297-300.
8. Naggie S., Miller B.A., Zuzak K.B., Pence B.W., Mayo A.J., Nicholson B.P., et al. A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. Am. J. Med. 2011, 124:276.e1-276.e7.
9. Otten A.M., Reid-Smith R.J., Fazil A., Weese J.S. Disease transmission model for community-associated Clostridium difficile infection. Epidemiol. Infect. 2010, 138:907-914.
10. Slimings C., Armstrong P., Beckingham W.D., Bull A.L., Hall L., Kennedy K.J., et al. Increasing incidence of Clostridium difficile infection, Australia, 2011-2012. Med. J. Aust. 2014, 200:272-276.
11. Tan X.Q., Verrall A.J., Jureen R., Riley T.V., Collins D.A., Lin R.T., et al. The emergence of community-onset Clostridium difficile infection in a tertiary hospital in Singapore: a cause for concern. Int. J. Antimicrob. Agents 2014, 43:47-51.
12. Center for Disease Control and Prevention (CDC) Severe Clostridium difficile-associated disease in populations previously at low risk-four states. MMWR 2005, 54:1201-1204.
13. Riley T.V., Wymer V., Bamford V.W., Bowman R.A. Clostridium difficile in general practice and community health. J. Hyg. (Lond) 1986, 96:13-17.
14. De Almeida M.N., Heffernan H., Dervan A., Bakker S., Freeman J.T., Bhally H., et al. Severe Clostridium difficile infection in New Zealand associated with an emerging strain, PCR-ribotype 244. N. Z. Med. J. 2013, 126:9-14.
15. Hensgens M.P., Keessen E.C., Squire M.M., Riley T.V., Koene M.G., de Boer E., et al. Clostridium difficile infection in the community: a zoonotic disease?. Clin. Microbiol. Infect. 2012, 18:635-645.
16. Bavishi C., Dupont H.L. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment. Pharmacol. Ther. 2011, 34:1269-1281.
17. Gupta A., Khanna S. Community-acquired Clostridium difficile infection: an increasing public health threat. Infect. Drug Resist 2014, 7:63-72.
18. Ozaki E., Kato H., Kita H., Karasawa T., Maegawa T., Koino Y., et al. Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization. J. Med. Microbiol. 2004, 53:167-172.
19. Jangi S., Lamont J.T. Asymptomatic colonization of Clostridium difficile in infants: implications for disease in later life. J. Pediatr. Gastroenterol. Nutr. 2010, 51:2-7.
20. McFarland L.V., Brandmarker S.A., Guandalini S. Pediatric Clostridium difficile: a phantom menace or clinical reality?. J. Pediatr. Gastroenterol. Nutr. 2000, 31:220-231.
21. Debast S.B., Bauer M.P., Kuijper E.J. European Society of Clinical Microbiology and Infectious Diseases: update on the treatment guidance document for Clostridium difficile infection. Clin. Microbiol. Infect. 2014, 20(Suppl. 2):1-26. on behalf of the Committee.
22. Cohen S.H., Gerding D.N., Johnson S., Kelly C.P., Loo V.G., McDonald L.C., et al. Clinical practice guidelines for Clostridium difficile in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol. 2010, 31:431-455.
23. Surawicz C.M., Brandt L.J., Binion D.G., Ananthakrishnan A.N., Curry S.C., Gilligan P.H., et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am. J. Gastroenterol. 2013, 108:478-498.
24. Kuijper E.J., Coignard B., Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin. Microbiol. Infect. 2006, 12(Suppl. 6):2-18. ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control.
25. Jamal W., Pauline E.M., Rotimi V.O. Comparative performance of the GeneXpert C. difficile PCR assay and C. diff Quik chek complete kit assay for detection of Clostridium difficile antigen and toxins in symptomatic community-onset infections. Int. J. Infect. Dis. 2014, 29:244-248.
26. Shahin M., Jamal W., Verghese T., Rotimi V.O. Comparative evaluation of anoxomat and conventional anaerobic GasPak jar systems for the isolation of anaerobic bacteria. Med. Princ. Pract. 2003, 12:81-86.
27. O'Neill G.L., Ogunsola F.T., Brazier J.S., Duerden B.I. Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 1996, 2:205-209.
28. Last J.M. A Dictionary of Epidemiology 2001, Oxford University Press, New York. fourth ed.
29. Hirschhorn L.R., Trnka Y., Onderdonk A., Lee M.L., Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J. Infect. Dis. 1994, 169:127-133.
30. Karlstrom O., Fryklund B., Tullus K., Burman L.G. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. Clin. Infect. Dis. 1998, 26:141-145. the Swedish C. difficile study Group.
31. Kuntz J.L., Chrischilles E.A., Pendergast J.F., Herwaldt L.A., Polgreen P.M. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect. Dis. 2011, 11:194.
32. Levy D.G., Stergachis A., McFarland L.V., Van Vorst K., Graham D.J., Johnson E.S., et al. Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting. Clin. Ther. 2000, 22:91-102.
33. Shin B.M., Moon S.J., Kim Y.S., Shin W.C., Yoo H.M. Characterization of cases of Clostridium difficile infection (CDI) presenting at an emergency room: molecular and clinical features differentiate community-onset hospital-associated and community-associated CDI in a tertiary care hospital. J. Clin. Microbiol. 2011, 49:2161-2165.
34. Dumyati G., Stevens V., Hannett G.E., Thompson A.D., Long C., MacCannell D., et al. Community-associated Clostridium difficile infections, Monroe county, New York, USA. Emerg. Infect. Dis. 2012, 18:392-400.
35. Dial S., Kezouh A., Dascal A., Barkun A., Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ 2008, 179:767-772.
36. Noren T., Akerlund T., Back E., Sjoberg Persson I., Alriksson I., et al. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J. Clin. Microbiol. 2004, 42:3635-3643.
37. Limbago B.M., Long C.M., Thompson A.D., Killgore G.E., Hannett G.E., Havill N.L., et al. Clostridium difficile strains from community-associated infections. J. Clin. Microbiol. 2009, 47:3004-3007.
38. Warny M., Pepin J., Fang A., Killgore G., Thompson A., Brazier J., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366:1079-1148.
39. Rotimi V.O., Jamal W.Y., Mokaddas E.M., Brazier J.S., Johny M., Duerden B.I. Prevalent PCR ribotypes of clinical and environmental strains of Clostridium difficile isolated from intensive-therapy unit patients in Kuwait. J. Med. Microbiol. 2003, 52:705-709.
40. Jamal W., Rotimi V.O., Brazier J., Duerden B.I. Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period. Anaerobe 2010, 16:560-565.
41. Huang H., Fang H., Weintraub A., Nord C.E. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Clin. Microbiol. Infect. 2009, 15:1170-1173.
42. Sawabe E., Kato H., Osawa K., Chida T., Tojo N., Arakawa Y., et al. Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a five-year period. Eur. J. Clin. Microbiol. Infect. Dis. 2007, 26:695-703.
43. Vanek J., Hill K., Collins J., Berrington A., Perry J., Inns T., et al. Epidemiological survey of Clostridium difficile ribotypes in the North East England during an 18-month period. J. Hosp. Infect. 2012, 81:209-212.
44. Bauer M.P., Veenendaal D., Verhoef L., Bloembergen P., van Dissel J.T., Kuijper E.J. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands. Clin. Microbiol. Infect. 2009, 15:1087-1092.
45. Bignardi G.E., Settle C. Different ribotypes in community-acquired Clostridium difficile. J. Hosp. Infect. 2008, 70:96-98.
46. Albert M.J., Rotimi V.O., Dhar R., Silpikurian S., Pacsa A.S., Molla M.A., et al. Diarrhoeagenic Escherichia coli are not a significant cause of diarrhoea in hospitalised children in Kuwait. BMC Microbiol. 2009, 9:62.